Sarepta Therapeutics Zooms Higher on Early Data Rally Promising
Sarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Before investing in cryptocurrency, it's crucial to understand the market. Learn key insights to prepare yourself for potential investments.
24,812 articlesSarepta Therapeutics surged about 20% after releasing early Phase 1/2 data for SRP-1001 and SRP-1003, signaling poten...
Global markets weigh climate risk as a likely Super El Niño could boost temperatures in 2027. This stock trader’s gui...
An experienced astronaut suddenly lost the ability to speak aboard the ISS, triggering a flurry of tests and question...
The latest Medicare Trustees forecast shows hospital insurance reserves depleting in Q2 2033, a quarter earlier than ...
A sub-$1 pre-IPO company behind a headset-first work platform says 1.5m+ people spend their work week in headsets. It...
Palantir surged about 9% after announcing a Sovereign-AI partnership with NVIDIA, aimed at secure, air-gapped governm...
Piper Sandler moved to downgrade its Fastly target after Q1 FY2026 showed slowing core delivery volumes. The stock dr...
The june jobs report came in well below forecasts, adding 57,000 payrolls and prompting a shift in Fed expectations a...
Investors are watching RFK Jr.’s carnivore diet stance as a health trend with potential implications for meat, dairy,...
Private AI leaders OpenAI and Anthropic see valuations near $1 trillion as investors chase growth. A cooling IPO wind...
A newly clarified rule lets unused 529 college-savings money roll into a Roth IRA, potentially producing substantial,...
A widow with $1.4 million in retirement assets faces a tax cliff once her spouse dies. The IRS treats her as a single...